Product Images Veozah

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Veozah NDC 0469-2660 by Astellas Pharma Us, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structural formula of fezolinetant - image 01

structural formula of fezolinetant - image 01

Package/Label Display Panel- VEOZAH Bottle Carton Label - image 02

Package/Label Display Panel- VEOZAH Bottle Carton Label - image 02

Package/Label Display Panel - VEOZAH Sample Bottle Carton Label - image 03

Package/Label Display Panel - VEOZAH Sample Bottle Carton Label - image 03

Package/Label Display Panel- VEOZAH Sampe Blister Carton - image 04

Package/Label Display Panel- VEOZAH Sampe Blister Carton - image 04

This is a description of the drug "VEOZAH" in tablet form with fezolinetant as its active ingredient. The recommended dosage is one tablet per day, to be taken orally and swallowed whole. Cutting, crushing, or chewing the tablets is not advisable. Each tablet contains 45g of fezolinetant. The drug must be stored at a temperature between 20°C to 25°C and must be kept out of reach of children. The manufacturer of the drug is Astelas Pharma US, Inc. The drug is not for sale. Contact 1-800-727-7003 or visit the website www.VEOZAH.com for further information.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.